leo 152020
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 31, 2020 (NCT04203836)
Timeline
Indications
Mechanism of action
- Histamine H4 receptorINHIBITOR
HRH4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05508776 | Phase 1 | Sep 16, 2022 | Leo Pharma |
| NCT05117060 | Phase 2 | Nov 10, 2021 | Leo Pharma |
| NCT04853992 | Phase 2 | May 10, 2021 | Leo Pharma |
| NCT04203836 | Phase 1 | Jan 31, 2020 | Leo Pharma |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Leo Pharma | For profit | 4 | 4 | 2 | 2020 |
1 organizations
Page 1 / 1